RNA biomarkers


  • biomarker discovery
  • biomarker signature identification
  • development of clinical-grade test
Picture of a human melanoma cell line growing in tissue culture

RNA therapies


  • targeting long non-coding RNA
  • using nucleic acid based-drugs


Deploying the transcriptome

At Biogazelle we are dedicated to deploy the transcriptome through excellence in science and technology.

We carefully select the best analytical platforms to offer customized RNA gene expression solutions to develop RNA targeted biomarkers and nucleic acid-based therapies.

We are fascinated by the complexity of the non-coding RNA world.

ISO 17025 logo

Biogazelle's solutions

Biomarker discovery

Our lab activities support the life science market at every level of the entire process: from RNA sequencing based discovery to PCR validation of biomarkers, from experiment design to result interpretation, from PCR assay design to research-use-only kits.

Learn more

RNA therapies

Using our proprietary and integrative target selection strategy, we prioritize long non-coding RNA genes as therapeutic targets in cancer. We combine large scale in vitro screens with preclinical animals models to develop nucleic acid based therapies.

Learn more


qbase+ is the most powerful and flexible real-time PCR data analysis software.

It's developed by experts for qPCR users belonging to all experience levels.

The software is packed with unique features to achieve high-quality results in a user-friendly manner.

Learn more

Current topics


Finalizing the new website for our RNA diagnostics & therapeutics! @qbaseplus 'll move completely to its own domain https://t.co/ex9Sn888Ql
18/08/2016 - 13:13
RT @pieter_mestdagh: Buried treasures in our genome. How long non-coding RNAs can contribute to the future of medicine. https://t.co/kCquWE
30/07/2016 - 12:21